To further investigate whether the aggravation of VDR/p53 pathway by vitamin D would contribute to brain pathology in AD mice, we investigated whether we could reverse the adverse effects of vitamin D on AD by administering p53 inhibitor PFTα. Here, TP53 is linked to Alzheimer disease.